Open and Fetoscopic Antenatal Myelomeningocele Repair

Status: draft · Last updated 2026-11-03 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • MOMS (repair before 26 weeks, hysterotomy):
    • Shunts 40% vs. 82%.
    • Hindbrain herniation 64% vs. 96%.
    • Independent ambulation 45% vs. 24%.
    • Cost: prematurity (mean 34 weeks; 13% born before 30 weeks), membrane rupture 46%, and a thin or dehisced hysterotomy in about a third .
  • Selection:
    • Lesion T1–S1, hindbrain herniation, 19–26 weeks, maternal BMI under 35, no severe kyphosis, and no high preterm risk.
    • Fetoscopic centers increasingly operate up to about 27 weeks .
  • Open vs. fetoscopic:
    • Fetoscopic avoids uterine scar dehiscence (0% vs. 34–49%) and allows vaginal birth .
    • It has more repair-site leak or dehiscence, and percutaneous approaches have more membrane rupture and prematurity .
    • Shunt and Chiari reversal rates are similar .
  • Future pregnancies after open repair: dehiscence 14% and rupture 14%. Cesarean delivery is mandatory .
  • Long term:
    • Bladder: less CIC (62% vs. 87%) and more volitional voiding at school age .
    • Shunt revisions: fewer .
    • Cognition: no gain .
    • Tethering: a possible increase (8% vs. 1% in MOMS), so follow for life .

Landmark papers

  • MOMS (Adzick et al., N Engl J Med 2011): a randomized trial of prenatal vs postnatal myelomeningocele repair. At 12 months, shunt placement was 40% vs 82% and any hindbrain herniation was 64% vs 96% .
  • MOMS full cohort (Farmer et al., Am J Obstet Gynecol 2018): at 30 months, independent ambulation was 44.8% vs 23.9% with prenatal vs postnatal repair, and cognitive scores did not differ .
  • International Fetoscopic Consortium (Sanz Cortes et al., Am J Obstet Gynecol 2021): a registry of 300 fetoscopic repairs. Uterine scar dehiscence or thinning was 0% vs 34% (MOMS) and 49% (post-MOMS open cohort) .

The Management of Myelomeningocele Study (MOMS) showed that repair before 26 weeks, through a hysterotomy, halves the need for shunting and improves motor function compared with postnatal repair. The cost is prematurity and uterine-scar risk . Fetoscopic techniques aim to keep the neurologic benefit while protecting the mother and future pregnancies .

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:fetal_mmc_repair:99b5e964bab3aeef© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Open repair through a stapled hysterotomy in an exteriorized uterus, and fetoscopic repair through ports into a carbon dioxide distended amniotic cavity, each with the prone fetus and its lumbosacral myelomeningocele and the placenta away from the entry sitesOPEN (HYSTEROTOMY)maternal abdomenhysterotomy, about6–8 cm, stapled edgesfetal MMC exposed fordirect repairuterus exteriorizedthrough a laparotomyuterine wallamniotic fluidplacenta: locationguides the incisionlaparotomy edgeFETOSCOPIC (PORTS)ports (trocars) withfetoscope and instrumentsamniotic cavity: CO₂above, fluid belowfetal MMC repairedthrough the portsuterine wallplacenta: locationguides port entrypercutaneous: ports through thematernal skin; laparotomy-assisted:uterus exteriorized, ports in its wallschematic side views at about 24 weeks; not to scale
Prenatal myelomeningocele repair at about 24 weeks (schematic side views). Top, open repair: the uterus is exteriorized through a maternal laparotomy, and a stapled hysterotomy of about 6–8 cm opens over the fetal back for direct repair of the lumbosacral myelomeningocele. Bottom, fetoscopic repair: ports carry a fetoscope and instruments into a CO₂-distended amniotic cavity, either percutaneously or after laparotomy with the uterus exteriorized. In both, placental location guides the entry site. Not to scale.

Patient selection

Technical differences

Maternal outcomes and complications

Fetal and neonatal outcomes and complications

Long-term outcomes

Related topics

References

  1. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011;364(11):993–1004. doi:10.1056/NEJMoa1014379. PMID 21306277. verified
  2. Sanz Cortes M, Chmait RH, Lapa DA, et al. Experience of 300 cases of prenatal fetoscopic open spina bifida repair: report of the International Fetoscopic Neural Tube Defect Repair Consortium. Am J Obstet Gynecol 2021;225(6):678.e1–678.e11. doi:10.1016/j.ajog.2021.05.044. PMID 34089698. verified
  3. Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Fetoscopic open neural tube defect repair: development and refinement of a two-port, carbon dioxide insufflation technique. Obstet Gynecol 2017;129(4):734–743. doi:10.1097/AOG.0000000000001941. PMID 28277363. verified
  4. Kohl T. Percutaneous fetoscopic patch coverage of spina bifida aperta in the human: early clinical experience and potential. Fetal Diagn Ther 2006;21(2):185–193. doi:10.1159/000089301. PMID 16491001. verified
  5. Trigo L, Chmait RH, Llanes A, et al. Revisiting MOMS criteria for prenatal repair of spina bifida: upper gestational-age limit should be raised and assessment of prenatal motor function rather than anatomical level improves prediction of postnatal function. Ultrasound Obstet Gynecol 2024;63(1):53–59. doi:10.1002/uog.27536. PMID 37970655. verified
  6. Lapa DA, Chmait RH, Gielchinsky Y, et al. Percutaneous fetoscopic spina bifida repair: effect on ambulation and need for postnatal cerebrospinal fluid diversion and bladder catheterization. Ultrasound Obstet Gynecol 2021;58(4):582–589. doi:10.1002/uog.23658. PMID 33880811. verified
  7. Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Comparison of two fetoscopic open neural tube defect repair techniques: single- vs three-layer closure. Ultrasound Obstet Gynecol 2020;56(4):532–540. doi:10.1002/uog.21915. PMID 31709658. verified
  8. Kabagambe SK, Jensen GW, Chen YJ, et al. Fetal surgery for myelomeningocele: a systematic review and meta-analysis of outcomes in fetoscopic versus open repair. Fetal Diagn Ther 2018;43(3):161–174. doi:10.1159/000479505. PMID 28910784. verified
  9. de Oliveira Júnior JP, Morais BA, Fernandes MNF, et al. Open repair versus fetoscopic fetal surgery: which is the best approach for intrauterine myelomeningocele correction? Systematic review and meta-analysis. Childs Nerv Syst 2025;41(1):256. doi:10.1007/s00381-025-06915-0. PMID 40779058. verified
  10. Johnson MP, Bennett KA, Rand L, et al. The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. Am J Obstet Gynecol 2016;215(6):778.e1–778.e9. doi:10.1016/j.ajog.2016.07.052. PMID 27496687. verified
  11. Wilson RD, Lemerand K, Johnson MP, et al. Reproductive outcomes in subsequent pregnancies after a pregnancy complicated by open maternal-fetal surgery (1996–2007). Am J Obstet Gynecol 2010;203(3):209.e1–209.e6. doi:10.1016/j.ajog.2010.03.029. PMID 20537307. verified
  12. Tulipan N, Wellons JC, Thom EA, et al. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 2015;16(6):613–620. doi:10.3171/2015.7.PEDS15336. PMID 26369371. verified
  13. Houtrow AJ, Thom EA, Fletcher JM, et al. Prenatal repair of myelomeningocele and school-age functional outcomes. Pediatrics 2020;145(2):e20191544. doi:10.1542/peds.2019-1544. PMID 31980545. verified
  14. Farmer DL, Thom EA, Brock JW, et al. The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol 2018;218(2):256.e1–256.e13. doi:10.1016/j.ajog.2017.12.001. PMID 29246577. verified
  15. Brock JW, Carr MC, Adzick NS, et al. Bladder function after fetal surgery for myelomeningocele. Pediatrics 2015;136(4):e906–e913. doi:10.1542/peds.2015-2114. PMID 26416930. verified
  16. Brock JW, Thomas JC, Baskin LS, et al. Effect of prenatal repair of myelomeningocele on urological outcomes at school age. J Urol 2019;202(4):812–818. doi:10.1097/JU.0000000000000334. PMID 31075056. verified
  17. Pastuszka A, Bohosiewicz J, Koszutski T. Prenatal myelomeningocele repair improves urinary continence and reduces the risk of constipation. Neurourol Urodyn 2018;37(8):2792–2798. doi:10.1002/nau.23771. PMID 30058735. verified
  18. Spoor JKH, Kik CC, van Veelen MC, et al. Potential higher risk of tethered spinal cord in children after prenatal surgery for myelomeningocele: a systematic review and meta-analysis. PLoS One 2023;18(6):e0287175. doi:10.1371/journal.pone.0287175. PMID 37379312. verified

Verification (2026-11-03): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed. The MOMS eligibility criteria, maternal complications, hysterotomy findings, gestational-age distribution, perinatal deaths, hindbrain herniation grades, tethered-cord surgery and epidermoid cyst rates were checked against the full text of reference 1 (PMC3770179). Preterm percentages before 37 weeks were summed from its table. Every other number was checked against the PubMed abstracts.

Caveats: